Skip to main content
Erschienen in: Cancer Causes & Control 10/2009

01.12.2009 | Brief report

Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort

verfasst von: Susanna C. Larsson, Leif Bergkvist, Alicja Wolk

Erschienen in: Cancer Causes & Control | Ausgabe 10/2009

Einloggen, um Zugang zu erhalten

Abstract

Background

Coffee and tea consumption has been inconsistently associated with the risk of breast cancer. We examined the associations of caffeinated coffee and black tea consumption with the incidence of breast cancer, overall and by estrogen receptor (ER) and progesterone receptor (PR) status of the tumor, in the Swedish Mammography Cohort.

Methods

We prospectively followed up 61,433 women who were cancer free at baseline in 1987–1990. Coffee and tea consumption was assessed with a food-frequency questionnaire administered at baseline and in 1997. Incident invasive breast cancer cases were ascertained by linkage with Swedish Cancer registers.

Results

Over a mean follow-up of 17.4 years, through December 2007, there were 2,952 incident cases of invasive breast cancer identified. Coffee consumption was not associated with risk of overall breast cancer (multivariate relative risk (RR) for ≥4 cups/day versus <1 cup/day = 1.02; 95% CI, 0.87–1.20) or with any subtype defined by ER and PR status. Black tea consumption was significantly positively associated with risk of overall breast cancer and ER+/PR+ tumors. The multivariate RRs comparing ≥2 cups/day of tea with no consumption were 1.22 (95% CI, 1.05–1.42) for overall breast cancer and 1.36 (95% CI, 1.09–1.69) for ER+/PR+ tumors.

Conclusion

Findings from this prospective study do not support a role of coffee consumption in the development of breast cancer but suggest that black tea consumption may be positively associated with risk of ER+/PR+ tumors.
Literatur
1.
Zurück zum Zitat Welsch CW, Scieszka KM, Senn ER, DeHoog JV (1983) Caffeine (1,3,7-trimethylxanthine), a temperature promoter of DMBA-induced rat mammary gland carcinogenesis. Int J Cancer 32:479–484CrossRefPubMed Welsch CW, Scieszka KM, Senn ER, DeHoog JV (1983) Caffeine (1,3,7-trimethylxanthine), a temperature promoter of DMBA-induced rat mammary gland carcinogenesis. Int J Cancer 32:479–484CrossRefPubMed
2.
Zurück zum Zitat VanderPloeg LC, Wolfrom DM, Rao AR, Braselton WE, Welsch CW (1992) Caffeine, theophylline, theobromine, and developmental growth of the mouse mammary gland. J Environ Pathol Toxicol Oncol 11:177–189PubMed VanderPloeg LC, Wolfrom DM, Rao AR, Braselton WE, Welsch CW (1992) Caffeine, theophylline, theobromine, and developmental growth of the mouse mammary gland. J Environ Pathol Toxicol Oncol 11:177–189PubMed
3.
Zurück zum Zitat IARC (1994) Monographs on the evaluation of carcinogenic risks to humans: some industrial chemicals. International Agency for Research on Cancer, Lyon IARC (1994) Monographs on the evaluation of carcinogenic risks to humans: some industrial chemicals. International Agency for Research on Cancer, Lyon
4.
Zurück zum Zitat Tang N, Zhou B, Wang B, Yu R (2008) Coffee consumption and risk of breast cancer: a metaanalysis. Am J Obstet Gynecol 200:290.e1–9CrossRef Tang N, Zhou B, Wang B, Yu R (2008) Coffee consumption and risk of breast cancer: a metaanalysis. Am J Obstet Gynecol 200:290.e1–9CrossRef
5.
Zurück zum Zitat Ganmaa D, Willett WC, Li TY et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071–2076CrossRefPubMed Ganmaa D, Willett WC, Li TY et al (2008) Coffee, tea, caffeine and risk of breast cancer: a 22-year follow-up. Int J Cancer 122:2071–2076CrossRefPubMed
6.
Zurück zum Zitat Ishitani K, Lin J, Manson JE, Buring JE, Zhang SM (2008) Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168:2022–2031CrossRefPubMed Ishitani K, Lin J, Manson JE, Buring JE, Zhang SM (2008) Caffeine consumption and the risk of breast cancer in a large prospective cohort of women. Arch Intern Med 168:2022–2031CrossRefPubMed
8.
Zurück zum Zitat Mattsson B, Wallgren A (1984) Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23:305–313CrossRefPubMed Mattsson B, Wallgren A (1984) Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol 23:305–313CrossRefPubMed
9.
Zurück zum Zitat Hu FB, Stampfer MJ, Rimm E et al (1999) Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531–540PubMed Hu FB, Stampfer MJ, Rimm E et al (1999) Dietary fat and coronary heart disease: a comparison of approaches for adjusting for total energy intake and modeling repeated dietary measurements. Am J Epidemiol 149:531–540PubMed
10.
Zurück zum Zitat Cox DR, Oakes D (1984) Analysis of survival data. Chapman & Hall, London Cox DR, Oakes D (1984) Analysis of survival data. Chapman & Hall, London
11.
Zurück zum Zitat Ferrini RL, Barrett-Connor E (1996) Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 144:642–644PubMed Ferrini RL, Barrett-Connor E (1996) Caffeine intake and endogenous sex steroid levels in postmenopausal women. The Rancho Bernardo Study. Am J Epidemiol 144:642–644PubMed
12.
Zurück zum Zitat Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS (2009) Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 115:2765–2774. doi:10.1002/cncr.24328 CrossRefPubMed Kotsopoulos J, Eliassen AH, Missmer SA, Hankinson SE, Tworoger SS (2009) Relationship between caffeine intake and plasma sex hormone concentrations in premenopausal and postmenopausal women. Cancer 115:2765–2774. doi:10.​1002/​cncr.​24328 CrossRefPubMed
13.
Zurück zum Zitat Nagata C, Kabuto M, Shimizu H (1998) Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer 30:21–24CrossRefPubMed Nagata C, Kabuto M, Shimizu H (1998) Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone-binding globulin in premenopausal Japanese women. Nutr Cancer 30:21–24CrossRefPubMed
14.
Zurück zum Zitat London S, Willett W, Longcope C, McKinlay S (1991) Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. Am J Clin Nutr 53:166–171PubMed London S, Willett W, Longcope C, McKinlay S (1991) Alcohol and other dietary factors in relation to serum hormone concentrations in women at climacteric. Am J Clin Nutr 53:166–171PubMed
16.
Zurück zum Zitat Kuruto-Niwa R, Inoue S, Ogawa S, Muramatsu M, Nozawa R (2000) Effects of tea catechins on the ERE-regulated estrogenic activity. J Agric Food Chem 48:6355–6361. doi:jf0008487[pii] CrossRefPubMed Kuruto-Niwa R, Inoue S, Ogawa S, Muramatsu M, Nozawa R (2000) Effects of tea catechins on the ERE-regulated estrogenic activity. J Agric Food Chem 48:6355–6361. doi:jf0008487[pii] CrossRefPubMed
Metadaten
Titel
Coffee and black tea consumption and risk of breast cancer by estrogen and progesterone receptor status in a Swedish cohort
verfasst von
Susanna C. Larsson
Leif Bergkvist
Alicja Wolk
Publikationsdatum
01.12.2009
Verlag
Springer Netherlands
Erschienen in
Cancer Causes & Control / Ausgabe 10/2009
Print ISSN: 0957-5243
Elektronische ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-009-9396-x

Weitere Artikel der Ausgabe 10/2009

Cancer Causes & Control 10/2009 Zur Ausgabe

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.